^
    2d
    Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria (clinicaltrials.gov)
    P2, N=240, Completed, Curacle Co., Ltd. | Recruiting --> Completed | Phase classification: P2b --> P2 | Trial completion date: Sep 2024 --> Nov 2025 | Trial primary completion date: Sep 2024 --> Nov 2025
    Trial completion • Phase classification • Trial completion date • Trial primary completion date
    |
    dimethyl fumarate (CU01)